Literature DB >> 1655447

Progress and challenges in the pathological diagnosis of myocarditis.

B M McManus1, L H Chow, S J Radio, S M Tracy, M A Beck, N M Chapman, K Klingel, R Kandolf.   

Abstract

The pathological diagnosis of myocarditis rests on well-described histopathological criteria. Appreciation for the disease-specific sensitivity of the endomyocardial biopsy, as well as the phenotypical and functional nature of inflammatory infiltrates, will enhance the clinical utility of the biopsy technique. New information regarding the role of enteroviruses in immunological sensitization and the study of enteroviruses in murine models and human patients are fostering new perspectives and routes of investigation of appropriate therapeutic interventions for myocarditis.

Entities:  

Mesh:

Year:  1991        PMID: 1655447     DOI: 10.1093/eurheartj/12.suppl_d.18

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.

Authors:  Honglin Luo; Jingchun Zhang; Frank Dastvan; Bobby Yanagawa; Michael A Reidy; Huifang M Zhang; Decheng Yang; Janet E Wilson; Bruce M McManus
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Honglin Luo; Bobby Yanagawa; Jingchun Zhang; Zongshu Luo; Mary Zhang; Mitra Esfandiarei; Christopher Carthy; Janet E Wilson; Decheng Yang; Bruce M McManus
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.

Authors:  Xiaoning Si; Bruce M McManus; Jingchun Zhang; Ji Yuan; Caroline Cheung; Mitra Esfandiarei; Agripina Suarez; Andrew Morgan; Honglin Luo
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.

Authors:  Ji Yuan; David A Stein; Travis Lim; Dexin Qiu; Shaun Coughlin; Zhen Liu; Yinjing Wang; Robert Blouch; Hong M Moulton; Patrick L Iversen; Decheng Yang
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

5.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

6.  Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes.

Authors:  Honglin Luo; Jingchun Zhang; Caroline Cheung; Agripina Suarez; Bruce M McManus; Decheng Yang
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Hsp70-1: upregulation via selective phosphorylation of heat shock factor 1 during coxsackieviral infection and promotion of viral replication via the AU-rich element.

Authors:  Ye Qiu; Xin Ye; Paul J Hanson; Huifang Mary Zhang; Jeff Zong; Brian Cho; Decheng Yang
Journal:  Cell Mol Life Sci       Date:  2015-09-11       Impact factor: 9.261

8.  Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.

Authors:  Guang Gao; Jingchun Zhang; Xiaoning Si; Jerry Wong; Caroline Cheung; Bruce McManus; Honglin Luo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-30       Impact factor: 4.733

9.  Advanced detection strategies for cardiotropic virus infection in a cohort study of heart failure patients.

Authors:  Paul J Hanson; Felicia Liu-Fei; Taylor A Minato; Al Rohet Hossain; Harpreet Rai; Victoria A Chen; Coco Ng; Kjetil Ask; Jeremy A Hirota; Bruce M McManus
Journal:  Lab Invest       Date:  2021-10-04       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.